Fujio-Vejar S, Vasquez Y, Morales P, Magne F, Vera-Wolf P, Ugalde JA, et al. The gut microbiota of healthy Chilean subjects reveals a high abundance of the phylum Verrucomicrobia. Front Microbiol. 2017 Jun 30;8(JUN).
DOI: 10.3389/fmicb.2017.01221
Adak A, Khan MR. An insight into gut microbiota and its functionalities. Cell Mol Life Sci [Internet]. 2019 Feb 15 [cited 2024 Feb 26];76(3):473–93. Availa-ble from: https://pubmed.ncbi.nlm.nih.gov/30317530/
DOI: 10.1007/s00018-018-2943-4
Álvarez-Calatayud G, Guarner F, Requena T, Marcos A. Dieta y microbiota. Impacto en la salud. Nutr Hosp. 2018 Sep 7;35(6).
DOI: 10.20960/nh.2280
Castillo-Álvarez F, Marzo-Sola ME. Papel de la microbiota intestinal en el desarrollo de diferentes enfermedades neurológicas. Neurología. 2022 Jul 1;37(6):492–8.
DOI: 10.1016/j.nrl.2019.03.017
Bhattarai Y, Kashyap PC. Parkinson’s disease: Are gut microbes involved? Am J Physiol Gastrointest Liver Physiol [Internet]. 2020 Oct 20 [cited 2021 May 12];319(5):G529–40. Available from: https://pubmed.ncbi.nlm.nih.gov/32877215/
DOI: 10.1152/ajpgi.00058.2020
Sampson TR, Debelius JW, Thron T, Janssen S, Shastri GG, Ilhan ZE, et al. Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Par-kinson’s Disease. Cell [Internet]. 2016 Dec 1 [cited 2022 Jun 7];167(6):1469-1480.e12. Available from: https://pubmed.ncbi.nlm.nih.gov/27912057/
DOI: 10.1016/j.cell.2016.11.018
Hamamah S, Aghazarian A, Nazaryan A, Hajnal A, Covasa M. Role of Microbi-ota-Gut-Brain Axis in Regulating Dopaminergic Signaling. Biomedicines. 2022 Feb 13;10(2):436.
DOI: 10.3390/biomedicines10020436
Góralczyk-Bińkowska A, Szmajda-Krygier D, Kozłowska E. The Microbiota-Gut-Brain Axis in Psychiatric Disorders. Int J Mol Sci [Internet]. 2022 Oct 1 [cited 2024 Feb 26];23(19). Available from: https://pubmed.ncbi.nlm.nih.gov/36232548/
DOI: 10.3390/ijms231911245
Arikan M, Yildiz Z, Kahraman Demir T, Yilmaz NH, Sen A, Hanoglu L, et al. Axillary Microbiota Is Associated with Cognitive Impairment in Parkinson’s Disease Patients. Microbiol Spectr [Internet]. 2022 Feb 23 [cited 2022 Jun 7];10(1). Available from: https://pubmed.ncbi.nlm.nih.gov/35138147/
DOI: 10.1128/spectrum.02358-21
Tian R, Hong J, Zhao J, Zhou D, Liu Y, Jiao Z, et al. Overall Structural Altera-tion of Gut Microbiota and Relationships with Risk Factors in Patients with Metabolic Syndrome Treated with Inulin Alone and with Other Agents: An Open-Label Pilot Study. Mediators Inflamm [Internet]. 2022 May 19 [cited 2022 Jul 28];2022:1–9. Available from: /pmc/articles/PMC9136633/
DOI: 10.1155/2022/2078520
Raymond JL, Morrow K. Dietoterapia. 15°. Elsevier, editor. Barcelona, España: 2021; 2021.
Paz TDSR, De Britto VLS, Yamaguchi B, Israel VL, Swarowsky A, Lourenço Correa C. Hand Function as Predictor of Motor Symptom Severity in Individu-als with Parkinson’s Disease. Gerontology [Internet]. 2021 Apr 1 [cited 2022 Nov 30];67(2):160–7. Available from: https://www.karger.com/Article/FullText/511910
DOI: 10.1159/000511910
Malmstrom TK, Miller DK, Simonsick EM, Ferrucci L, Morley JE. SARC‐F: a symptom score to predict persons with sarcopenia at risk for poor functional outcomes. J Cachexia Sarcopenia Muscle [Internet]. 2016 Mar 1 [cited 2022 Nov 30];7(1):28. Available from: /pmc/articles/PMC4799853/
DOI: 10.1002/jcsm.12048
Rubenstein LZ, Harker JO, Salvà A, Guigoz Y, Vellas B. Screening for Under-nutrition in Geriatric PracticeDeveloping the Short-Form Mini-Nutritional As-sessment (MNA-SF). The Journals of Gerontology: Series A [Internet]. 2001 Jun 1 [cited 2022 Nov 30];56(6):M366–72. Available from: https://academic.oup.com/biomedgerontology/article/56/6/M366/526432
DOI: 10.1093/gerona/56.6.M366
Durán Agüero S, Candia P, Mena RP. Validación de contenido de la Encuesta de Calidad de Alimentación del Adulto Mayor (ECAAM). Nutr Hosp [Internet]. 2017 Nov 14 [cited 2022 Nov 30];34(6):1311–8. Available from: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112017000900009&lng=es&nrm=iso&tlng=es
Lai H, Li Y, He Y, Chen F, Mi B, Li J, et al. Effects of dietary fibers or probiot-ics on functional constipation symptoms and roles of gut microbiota: a double-blinded randomized placebo trial. Gut Microbes. 2023 Dec 31;15(1).
DOI: 10.1080/19490976.2023.2197837
Miranda M V., González FC, Paredes-Godoy OS, Maulén MA, Vásquez† CC, Díaz-Vásquez WA. Characterization of metal(loid)s and antibiotic resistance in bacteria of human gut microbiota from chronic kidney disease subjects. Biol Res [Internet]. 2022 Dec 1 [cited 2024 Feb 28];55(1):1–12. Available from: https://link.springer.com/articles/10.1186/s40659-022-00389-z
DOI: 10.1186/s40659-022-00389-z
Bergström A, Licht TR, Wilcks A, Andersen JB, Schmidt LR, Grønlund HA, et al. Introducing GUt Low-Density Array (GULDA) - a validated approach for qPCR-based intestinal microbial community analysis. FEMS Microbiol Lett. 2012 Dec;337(1):38–47.
DOI: 10.1111/1574-6968.12004
Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turn-baugh PJ, et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A [Internet]. 2011 Mar 15 [cited 2022 Nov 15];108 Suppl 1(Suppl 1):4516–22. Available from: https://pubmed.ncbi.nlm.nih.gov/20534432/
DOI: 10.1073/pnas.1000080107
Zilli Canedo Silva M, Carol Fritzen N, de Oliveira M, Paes da Silva M, Rasmus-sen Petterle R, Teive HA, et al. Protein intake, nitrogen balance and nutritional status in patients with Parkinson’s disease; time for a change? Nutr Hosp. 2015 Jun 1;31(6):2764–70.
SENPE; SEGG. SENPE SOCIEDAD ESPAÑOLA DE NUTRICIÓN PARENTE-RAL Y ENTERAL SEGG SOCIEDAD ESPAÑOLA DE GERIATRÍA Y GE-RONTOLOGÍA.
Budrewicz S, Zmarzły A, Rączka D, Szczepańska A, Koziorowska-Gawron E, Słotwiński K, et al. Clinical and nutritional correlations in Parkinson’s disease: Preliminary report. Advances in Clinical and Experimental Medicine [Internet]. 2019 Feb 1 [cited 2021 Jun 23];28(2):193–8. Available from: https://pubmed.ncbi.nlm.nih.gov/29963785/
DOI: 10.17219/acem/76375
Giuri D, Ravarino P, Tomasini C. L-Dopa in small peptides: an amazing func-tionality to form supramolecular materials. Org Biomol Chem. 2021;19(21):4622–36.
DOI: 10.1039/D1OB00378J
Leta V, Klingelhoefer L, Longardner K, Campagnolo M, Levent HÇ, Aureli F, et al. Gastrointestinal barriers to levodopa transport and absorption in Parkinson’s disease. Eur J Neurol. 2023 May 7;30(5):1465–80.
DOI: 10.1111/ene.15734
Laudisio A, Vetrano DL, Meloni E, Ricciardi D, Franceschi F, Bentivoglio AR, et al. Dopaminergic agents and nutritional status in Parkinson’s disease. Move-ment Disorders. 2014 Oct;29(12):1543–7.
DOI: 10.1002/mds.25991
Sharma S, Awasthi A, Singh S. Altered gut microbiota and intestinal permeabil-ity in Parkinson’s disease: Pathological highlight to management. Neurosci Lett. 2019 Nov 1;712:134516.
DOI: 10.1016/j.neulet.2019.134516
Rekdal VM, Bess EN, Bisanz JE, Turnbaugh PJ, Balskus EP. Discovery and in-hibition of an interspecies gut bacterial pathway for Levodopa metabolism. Sci-ence [Internet]. 2019 Jun 14 [cited 2021 Dec 26];364(6445):1055. Available from: /pmc/articles/PMC7745125/
DOI: 10.1126/science.aau6323
Huang Y, Liao J, Liu X, Zhong Y, Cai X, Long L. Review: The Role of Intestinal Dysbiosis in Parkinson’s Disease. Front Cell Infect Microbiol [Internet]. 2021 Apr 22 [cited 2021 Dec 22];11. Available from: https://pubmed.ncbi.nlm.nih.gov/33968794/
DOI: 10.3389/fcimb.2021.615075
van Kessel SP, de Jong HR, Winkel SL, van Leeuwen SS, Nelemans SA, Per-mentier H, et al. Gut bacterial deamination of residual levodopa medication for Parkinson’s disease. BMC Biol [Internet]. 2020 Dec 1 [cited 2022 Jul 13];18(1). Available from: https://pubmed.ncbi.nlm.nih.gov/33076930/
DOI: 10.1186/s12915-020-00876-3
Jameson KG, Hsiao EY. A novel pathway for microbial metabolism of Levodo-pa. Nat Med [Internet]. 2019 Aug 1 [cited 2022 Jul 13];25(8):1195. Available from: /pmc/articles/PMC7004239/
DOI: 10.1038/s41591-019-0544-x
Su H, Chen J, Miao S, Deng K, Liu J, Zeng S, et al. Lotus seed oligosaccharides at various dosages with prebiotic activity regulate gut microbiota and relieve constipation in mice. Food and Chemical Toxicology. 2019 Dec 1;134:110838.
DOI: 10.1016/j.fct.2019.110838
Lan J, Wang K, Chen G, Cao G, Yang C. Effects of inulin and isomalto-oligosaccharide on diphenoxylate-induced constipation, gastrointestinal motili-ty-related hormones, short-chain fatty acids, and the intestinal flora in rats. Food Funct [Internet]. 2020 Oct 1 [cited 2022 Jul 13];11(10):9216–25. Available from: https://pubmed.ncbi.nlm.nih.gov/33030479/
DOI: 10.1039/D0FO00865F
Heaton KW, Radvan J, Cripps H, Mountford RA, Braddon FEM, Hughes AO. Defecation frequency and timing, and stool form in the general population: a prospective study. Gut [Internet]. 1992 [cited 2022 Jul 13];33(6):818. Available from: /pmc/articles/PMC1379343/?report=abstract
DOI: 10.1136/gut.33.6.818
Leiva AM, Martínez-Sanguinetti MA, Troncoso-Pantoja C, Nazar G, Peter-mann-Rocha F, Celis-Morales C. Chile lidera el ranking latinoamericano de prevalencia de enfermedad de Parkinson. Rev Med Chil. 2019 Apr;147(4):535–6.
DOI: 10.4067/S0034-98872019000400535
Nishiwaki H, Ito M, Ishida T, Hamaguchi T, Maeda T, Kashihara K, et al. Meta-Analysis of Gut Dysbiosis in Parkinson’s Disease. Movement Disorders [Inter-net]. 2020 Sep 1 [cited 2021 Dec 26];35(9):1626–35. Available from: https://onlinelibrary.wiley.com/doi/full/10.1002/mds.28119
DOI: 10.1002/mds.28119
Nishiwaki H, Hamaguchi T, Ito M, Ishida T, Maeda T, Kashihara K, et al. Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson’s Dis-ease but Not in Rapid-Eye-Movement Sleep Behavior Disorder. mSystems [In-ternet]. 2020 Dec 22 [cited 2022 Jul 30];5(6). Available from: /pmc/articles/PMC7771407/
DOI: 10.1128/mSystems.00797-20
Fang X, Li F jun, Hong D jun. Potential Role of Akkermansia muciniphila in Parkinson’s Disease and Other Neurological/Autoimmune Diseases. Curr Med Sci [Internet]. 2021 Dec 1 [cited 2022 Jul 30];41(6):1172–7. Available from: https://pubmed.ncbi.nlm.nih.gov/34893951/
DOI: 10.1007/s11596-021-2464-5
Yan Z, Yang F, Cao J, Ding W, Yan S, Shi W, et al. Alterations of gut microbio-ta and metabolome with Parkinson’s disease. Microb Pathog. 2021 Nov 1;160:105187.
DOI: 10.1016/j.micpath.2021.105187
Pisciotta MS, Fusco D, Grande G, Brandi V, Lo Monaco MR, Laudisio A, et al. Untangling the relationship between fat distribution, nutritional status and Par-kinson’s disease severity. Aging Clin Exp Res [Internet]. 2020 Jan 1 [cited 2021 Jun 23];32(1):77–84. Available from: https://pubmed.ncbi.nlm.nih.gov/30877644/
DOI: 10.1007/s40520-019-01166-x